Literature DB >> 16023348

Morpheeins--a new structural paradigm for allosteric regulation.

Eileen K Jaffe1.   

Abstract

Classic models for the allosteric regulation of protein function consider an equilibrium among protein structures of constant oligomeric multiplicity. The morpheein (mor-phee'-in) concept expands this model to include a dynamic equilibrium of protein structures wherein a protein monomer can exist in more than one conformation and each monomer conformation dictates a different quaternary structure of finite multiplicity and different functionality. The morpheein concept provides a new framework for understanding allosteric regulation, kinetic cooperativity and hysteresis. Porphobilinogen synthase constitutes a prototype morpheein ensemble comprising several interconverting quaternary structure isoforms; one monomer conformation dictates assembly of a high-activity octamer, whereas an alternative monomer conformation dictates assembly of a low-activity hexamer. It is proposed here that the behavior of some other allosteric enzymes reflect dynamic morpheein equilibrium systems and six candidate proteins are enumerated.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16023348     DOI: 10.1016/j.tibs.2005.07.003

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  64 in total

1.  ALAD porphyria is a conformational disease.

Authors:  Eileen K Jaffe; Linda Stith
Journal:  Am J Hum Genet       Date:  2006-12-21       Impact factor: 11.025

Review 2.  A boolean network modelling of receptor mosaics relevance of topology and cooperativity.

Authors:  L F Agnati; D Guidolin; G Leo; K Fuxe
Journal:  J Neural Transm (Vienna)       Date:  2006-09-12       Impact factor: 3.575

Review 3.  Intramembrane receptor-receptor interactions: a novel principle in molecular medicine.

Authors:  K Fuxe; M Canals; M Torvinen; D Marcellino; A Terasmaa; S Genedani; G Leo; D Guidolin; Z Diaz-Cabiale; A Rivera; L Lundstrom; U Langel; J Narvaez; S Tanganelli; C Lluis; S Ferré; A Woods; R Franco; L F Agnati
Journal:  J Neural Transm (Vienna)       Date:  2006-10-27       Impact factor: 3.575

Review 4.  Structure, function, and mechanism of proline utilization A (PutA).

Authors:  Li-Kai Liu; Donald F Becker; John J Tanner
Journal:  Arch Biochem Biophys       Date:  2017-07-14       Impact factor: 4.013

5.  Biophysical investigation of type A PutAs reveals a conserved core oligomeric structure.

Authors:  David A Korasick; Harkewal Singh; Travis A Pemberton; Min Luo; Richa Dhatwalia; John J Tanner
Journal:  FEBS J       Date:  2017-08-01       Impact factor: 5.542

6.  Expanding the Concepts in Protein Structure-Function Relationships and Enzyme Kinetics: Teaching using Morpheeins.

Authors:  Sarah H Lawrence; Eileen K Jaffe
Journal:  Biochem Mol Biol Educ       Date:  2008       Impact factor: 1.160

7.  Probing the oligomeric assemblies of pea porphobilinogen synthase by analytical ultracentrifugation.

Authors:  Bashkim Kokona; Daniel J Rigotti; Andrew S Wasson; Sarah H Lawrence; Eileen K Jaffe; Robert Fairman
Journal:  Biochemistry       Date:  2008-09-17       Impact factor: 3.162

Review 8.  Theoretical considerations on the topological organization of receptor mosaics.

Authors:  Agnati Luigi Francesco; Fuxe Kjell; Woods Amina; Genedani Susanna; Guidolin Diego
Journal:  Curr Protein Pept Sci       Date:  2009-12       Impact factor: 3.272

9.  The positively charged region of the myosin IIC non-helical tailpiece promotes filament assembly.

Authors:  Daniel Ronen; Masha M Rosenberg; Deborah E Shalev; Michael Rosenberg; Shahar Rotem; Assaf Friedler; Shoshana Ravid
Journal:  J Biol Chem       Date:  2009-12-03       Impact factor: 5.157

10.  Architecture and assembly of HIV integrase multimers in the absence of DNA substrates.

Authors:  Ravi Shankar Bojja; Mark D Andrake; George Merkel; Steven Weigand; Roland L Dunbrack; Anna Marie Skalka
Journal:  J Biol Chem       Date:  2013-01-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.